Search

everythinglearnresearchcommunity

for

Search:↓

Severe COVID-19 may increase lung cancer risk and affect treatment in women due to hormonal changes.

A 13-year-old with 46 XY DSD had ambiguous genitalia due to incomplete masculinization.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Gene mutations can cause problems in male genital development.

Hair growth is controlled by cell interactions and influenced by specific growth factors and hormones.

Male pattern baldness is mainly caused by a hormone called dihydrotestosterone (DHT), and drugs that can block this hormone might help prevent hair loss.

Certain medications can negatively impact male fertility.

The meeting covered advances in understanding hair growth, causes of hair loss, and potential treatments.

COCs can improve acne but may cause skin issues like cholasma; high estrogen is advised for hair loss concerns.

Hirsutism is excessive male-pattern hair growth mainly caused by ovarian hormones, and severe cases may require costly treatment with side effects.

Men with early hair loss and certain health factors may have a higher risk of developing reproductive issues, similar to polycystic ovary syndrome in women.

Ayurvedic treatment improved PCOS symptoms and hormone levels.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The testes produce important hormones like testosterone and others that play key roles in male body functions.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.